Zhi-qiao Liu
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multimodal prognostic model for de novo metastatic nasopharyngeal carcinoma after first-line immunochemotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 13, 2025
Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
Journal: European radiology
Published: November 09, 2023
Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma.
Journal: Oral oncology
Published: June 19, 2023
Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study.
Journal: EClinicalMedicine
Published: April 20, 2023
Deep learning-based precise prediction and early detection of radiation-induced temporal lobe injury for nasopharyngeal carcinoma.
Journal: EClinicalMedicine
Published: January 01, 2023
Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis.
Journal: Radiation oncology (London, England)
Published: August 13, 2022
Benefit of [18F] FDG PET/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 23, 2022
Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: June 11, 2022
Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.
Journal: Cancer medicine
Published: November 02, 2021
Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma.
Journal: European radiology
Published: June 08, 2021
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 03, 2021
Last Updated: 09/26/2026